Pathogenesis of acute and chronic central nervous system infection with variants of mouse hepatitis virus, strain JHM

Immunologic Research

Volumn 39, Issue 1-3, 2007, Pages 160-172

  Templeton, Steven P ^a   Perlman, Stanley ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

CNS; Demyelination; MHV JHM; Neurovirulence; Viral infection

Indexed keywords

GLYCOPROTEIN; MYELIN; VIRUS ANTIBODY;

ACUTE DISEASE; ANTIVIRAL ACTIVITY; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM INFECTION; CHRONIC DISEASE; DEMYELINATING DISEASE; DEMYELINATION; DISEASE COURSE; DISEASE MODEL; ENCEPHALITIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HOST RESISTANCE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; MURINE HEPATITIS CORONAVIRUS; NERVE FIBER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS VIRULENCE;

ACUTE DISEASE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CHEMOKINES; CHRONIC DISEASE; CORONAVIRUS INFECTIONS; DEMYELINATING DISEASES; MICE; MURINE HEPATITIS VIRUS; VIRULENCE;

EID: 35348815545     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-007-0079-y     Document Type: Review

References (80)

1. Bergmann CC, Lane TE, Stohlman SA. Coronavirus infection of the central nervous system: host-virus stand-off. Nat Rev Microbiol 2006;4:121-32.
2. Griffin DE. Immune responses to RNA-virus infections of the CNS. Nat Rev Immunol 2003;3:493-502.
3. Hickey WF. Basic principles of immunological surveillance of the normal central nervous system. Glia 2001;36:118-24.
4. Perlman S, Dandekar AA. Immunopathogenesis of coronavirus infections: implications for SARS. Nat Rev Immunol 2005;5:917-27.
5. Stohlman SA, Bergmann CC, Perlman S. Mouse hepatitis virus. In: Ahmed R, Chen I, editors. Persistent viral infections. John Wiley & Sons, Ltd.; 1998. p. 537-557.
6. Fischer F, Stegen C, Koetzner CA, Masters PS. Analysis of a recombinant mouse hepatitis virus expressing a foreign gene reveals a novel aspect of coronavirus transcription. J Virol 1997;71:5148-60.
7. Kuo L, Godeke GJ, Raamsman MJ, Masters PS, Rottier PJ. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J Virol 2000;74:1393-406.
8. Masters PS. Reverse genetics of the largest RNA viruses. Adv Virus Res 1999;53:245-64.
9. Phillips JJ, Chua MM, Lavi E, Weiss SR. Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence. J Virol 1999;73:7752-60.
10. Ontiveros E, Kuo L, Masters PS, Perlman S. Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS. Virology 2001;290:230-8.
11. Yokomori K, Lai MMC. Mouse hepatitis virus S RNA sequence reveals that nonstructural protein ns4 and ns5a are not essential for murine coronavirus replication. J Virol 1991;65:5605-8.
12. Kim TS, Perlman S. Viral expression of CCL2 is sufficient to induce demyelination in RAG1-/- mice infected with a neurotropic coronavirus. J Virol 2005;79:7113-20.
13. Ontiveros E, Kim TS, Gallagher TM, Perlman S. Enhanced virulence mediated by the murine coronavirus, mouse hepatitis virus Strain JHM, Is associated with a glycine at residue 310 of the spike glycoprotein. J Virol 2003;77:10260-9.
14. Pewe L, Zhou H, Netland J, Tangadu C, Olivares H, Shi L, et al. A severe acute respiratory syndrome-associated coronavirus-specific protein enhances virulence of an attenuated murine coronavirus. J Virol 2005;79:11335-42.
15. Hemmer B, Archelos JJ, Hartung HP. New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 2002;3:291-301.
16. Sospedra M, Martin R. Immunology of multiple sclerosis. Ann Rev Immunol 2005;23:683-747.
17. Buchmeier MJ, Lewicki HA, Talbot PJ, Knobler RL. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 1984;132:261-70.
18. Perlman S, Schelper R, Bolger E, Ries D. Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody. Microb Pathog 1987;2:185-94.
19. Houtman JJ, Fleming JO. Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM. J Neurovirol 1996;2:101-10.
20. Wang F, Stohlman SA, Fleming JO. Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J Neuroimmunol 1990;30:31-41.
21. Wu GF, Dandekar AA, Pewe L, Perlman S. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J Immunol 2000;165:2278-86.
22. Kim TS, Perlman S. Virus-specific antibody, in the absence of T cells, mediates demyelination in mice infected with a neurotropic coronavirus. Am J Pathol 2005;166:801-9.
23. Iacono KT, Kazi L, Weiss SR. Both spike and background genes contribute to murine coronavirus neurovirulence. J Virol 2006;80:6834-43.
24. Rempel JD, Murray SJ, Meisner J, Buchmeier MJ. Differential regulation of innate and adaptive immune responses in viral encephalitis. Virology 2004;318:381-92.
25. Rempel JD, Murray SJ, Meisner J, Buchmeier MJ. Mouse hepatitis virus neurovirulence: evidence of a linkage between S glycoprotein expression and immunopathology. Virology 2004;318:45-54.
26. Castro RF, Perlman S. CD8+ T cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J Virol 1995;69:8127-31.
27. + T cell epitope within the M protein of a neurotropic coronavirus. Virology 1995;208:173-9.
28. Pewe L, Heard SB, Bergmann CC, Dailey MO, Perlman S. Selection of CTL escape mutants in mice infected with a neurotropic coronavirus: Quantitative estimate of TCR diversity in the infected CNS. J Immunol 1999;163:6106-13.
29. Touil T, Fitzgerald D, Zhang GX, Rostami A, Gran B. Cutting Edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta. J Immunol 2006;177:7505-9.
30. Teige I, Liu Y, Issazadeh-Navikas S. IFN-beta inhibits T cell activation capacity of central nervous system APCs. J Immunol 2006;177:3542-53.
31. Dikopoulos N, Bertoletti A, Kroger A, Hauser H, Schirmbeck R, Reimann J. Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells. J Immunol 2005;174:99-109.
32. Ejrnaes M, Filippi CM, Martinic MM, Ling EM, Togher LM, Crotty S, et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 2006;203:2461-72.
33. Liu XS, Xu Y, Hardy L, Khammanivong V, Zhao W, Fernando GJ, et al. IL-10 mediates suppression of the CD8 T cell IFN-gamma response to a novel viral epitope in a primed host. J Immunol 2003;171:4765-72.
34. Rouse BT, Sarangi PP, Suvas S. Regulatory T cells in virus infections. Immunol Rev 2006;212:272-86.
35. Delhaye S, Paul S, Blakqori G, Minet M, Weber F, Staeheli P, et al. Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A 2006;103:7835-40.
36. Liu Y, Teige I, Birnir B, Issazadeh-Navikas S. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med 2006;12:518-25.
37. Ploegh HL. Viral strategies of immune evasion. Science 1998;280:248-53.
38. Pewe L, Wu G, Barnett EM, Castro R, Perlman S. Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity 1996;5:253-62.
39. Hudrisier D, Oldstone MB, Gairin JE. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules. Virology 1997;234:62-73.
40. Kim TS, Perlman S. Protection against CTL escape and clinical disease in a murine model of virus persistence. J Immunol 2003;171:2006-13.
41. Anghelina D, Pewe L, Perlman S. Pathogenic role for virus-specific CD4 T cells in mice with coronavirus-induced acute encephalitis. Am J Pathol 2006;1:209-22.
42. Liu T, Chambers TJ. Yellow fever virus encephalitis: properties of the brain-associated T-cell response during virus clearance in normal and gamma interferon-deficient mice and requirement for CD4+ lymphocytes. J Virol 2001;75:2107-18.
43. Murali-Krishna K, Ravi V, Manjunath R. Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells. J Gen Virol 1996;77(Pt 4):705-14.
44. Weidinger G, Henning G, ter Meulen V, Niewiesk S. Inhibition of major histocompatibility complex class II-dependent antigen presentation by neutralization of gamma interferon leads to breakdown of resistance against measles virus-induced encephalitis. J Virol 2001;75:3059-65.
45. Fleming JO, Trousdale MD, Bradbury J, Stohlman SA, Weiner LP. Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease. Microb Pathog 1987;3:9-20.
46. Fleming JO, Trousdale MD, El-Zaatari F, Stohlman SA, Weiner LP. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol 1986;58:869-75.
47. Fleming JO, Adami C, Pooley J, Glomb J, Stecker E, Fazal F, et al. Mutations associated with viral sequences isolated from mice persistently infected with MHV-JHM. Adv Exp Med Biol 1995;380:591-5.
48. Fazakerley JK, Buchmeier MJ. Pathogenesis of virus-induced demyelination. Adv Virus Res 1993;42:249-324.
49. McMahon EJ, Bailey SL, Castenada CV, Waldner H, Miller SD. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 2005;11:335-9.
50. Dandekar AA, Jacobsen G, Waldschmidt TJ, Perlman S. Antibody-mediated protection against cytotoxic T-cell escape in coronavirus-induced demyelination. J Virol 2003;77:11867-74.
51. Xue S, Sun N, van Rooijen N, Perlman S. Depletion of blood-borne macrophages does not reduce demyelination in mice infected with a neurotropic coronavirus. J Virol 1999;73:6327-34.
52. Houtman JJ, Fleming JO. Pathogenesis of mouse hepatitis virus-induced demyelination. J Neurovirol 1996;2:361-76.
53. Wu GF, Perlman S. Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus. J Virol 1999;73:8771-80.
54. Pewe L, Haring J, Perlman S. CD4 T-cell-mediated demyelination is increased in the absence of gamma interferon in mice infected with mouse hepatitis virus. J Virol 2002;76:7329-33.
55. Pewe LL, Perlman S. CD8 T cell-mediated demyelination is IFN-γ dependent in mice infected with a neurotropic coronavirus. J Immunol 2002;168:1547-51.
56. Parra B, Hinton D, Marten N, Bergmann C, Lin MT, Yang CS, Stohlman SA. IFN-γ(is required for viral clearance from central nervous system oligodendroglia. J Immunol 1999;162:1641-47.
57. Huseby ES, Liggitt D, Brabb T, Schnabel B, Ohlen C, Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med 2001;194:669-76.
58. Tran EH, Prince EN, Owens T. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. J Immunol 2000;164:2759-68.
59. Held KS, Chen BP, Kuziel WA, Rollins BJ, Lane TE. Differential roles of CCL2 and CCR2 in host defense to coronavirus infection. Virology 2004;329:251-60.
60. Brisebois M, Zehntner SP, Estrada J, Owens T, Fournier S. A pathogenic role for CD8+ T cells in a spontaneous model of demyelinating disease. J Immunol 2006;177:2403-11.
61. Dandekar AA, Perlman S. Virus-induced demyelination in nude mice is mediated by gamma delta T cells. Am J Pathol 2002;161:1255-63.
62. Dandekar AA, O'Malley K, Perlman S. Important roles for gamma interferon and NKG2D in γδ T cell-induced demyelination in TCRβ-deficient mice infected with a coronavirus. J Virol 2005;79:9388-96.
63. Kobayashi Y, Kawai K, Ito K, Honda H, Sobue G, Yoshikai Y. Aggravation of murine experimental allergic encephalomyelitis by administration of T-cell receptor gammadelta-specific antibody. J Neuroimmunol 1997;73:169-74.
64. Odyniec A, Szczepanik M, Mycko MP, Stasiolek M, Raine CS, Selmaj KW. Gammadelta T cells enhance the expression of experimental autoimmune encephalomyelitis by promoting antigen presentation and IL-12 production. J Immunol 2004;173:682-94.
65. Ponomarev ED, Novikova M, Yassai M, Szczepanik M, Gorski J, Dittel BN. Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis. J Immunol 2004;173:1587-95.
66. Rajan AJ, Gao YL, Raine CS, Brosnan CF. A pathogenic role for γδ T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse. J Immunol 1996;157:941-9.
67. Spahn TW, Issazadah S, Salvin AJ, Weiner HL. Decreased severity of myelin oligodendrocyte glycoprotein peptide 33-35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR δ chain gene. Eur J Immunol 1999;29:4060-71.
68. Archelos JJ, Storch MK, Hartung HP. The role of B cells and autoantibodies in multiple sclerosis. Ann Neurol 2000;47:694-706.
69. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000;47:707-17.
70. Wingerchuk DM, Lucchinetti CF, Noseworthy JH. Multiple sclerosis: current pathophysiological concepts. Lab Invest 2001;81:263-81.
71. Owens GP, Ritchie AM, Burgoon MP, Williamson RA, Corboy JR, Gilden DH. Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J Immunol 2003;171:2725-33.
72. Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, et al. Multiple sclerosis and Epstein-Barr virus. JAMA 2003;289:1533-6.
73. Burgoon MP, Hammack BN, Owens GP, Maybach AL, Eikelenboom MJ, Gilden DH. Oligoclonal immunoglobulins in cerebrospinal fluid during varicella zoster virus (VZV) vasculopathy are directed against VZV. Ann Neurol 2003;54:459-63.
74. Abdul-Majid KB, Stefferl A, Bourquin C, Lassmann H, Linington C, Olsson T, et al. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scand J Immunol 2002;55:70-81.
75. Barnum SR, Szalai AJ. Complement and demyelinating disease: no MAC needed? Brain research 2006;52:58-68.
76. Nataf S, Carroll SL, Wetsel RA, Szalai AJ, Barnum SR. Attenuation of experimental autoimmune demyelination in complement-deficient mice. J Immunol 2000;165:5867-73.
77. Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 2006;12:682-7.
78. Glabinski AR, Tani M, Tuohy VK, Tuthill RJ, Ransohoff RM. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain Behav Immun 1995;9:315-30.
79. Izikson L, Klein RS, Luster AD, Weiner HL. Targeting monocyte recruitment in CNS autoimmune disease. Clin Immunol 2002;103:125-31.
80. Chen BP, Kuziel WA, Lane TE. Lack of CCR2 results in increased mortality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus. J Immunol 2001;167:4585-92.